2021
- AugCompleted 200 million round B financing
- MayDistribute the third batch of employee incentive options
- AprNaltrexone implant was listed as a breakthrough treatment drug by National Medical Prouducts Administration
2020
- NovThe second batch of options were distributed, and the Series B financing was started
- JunPhase II clinical trial of naltrexone implant completed
- FebSciencare Medical has completed a round A financing of 120 million yuan , with investors from Shenzhen Capital Group co.,ltd. Xiaoxiang Capital co.,ltd. , People's Daily Online, Beijing Jingchuang Biotechnology and other institutions.
- JanThe construction project of the naltrexone implant production line was officially launched.
2019
- DecThe enrollment of the Phase II clinical trial of naltrexone implant was completed and the trial progressed smoothly.
- AprShenzhen Sciencare Medical Industries Co., Ltd.'s drug delivery system engineering research center was officially opened in Pingshan, Shenzhen.
- MarThe employee option incentive plan was launched and the first batch of options was distributed.
2018
- AugNaltrexone implants started phase II clinical trials.
- JunSciencare started the construction of a production base in Changfang Industrial Park, Pingshan District, Shenzhen.
2017
- OctFunds such as Shenzhen Capital fortune co.,ltd. and Zijingang Capital co.,ltd. reorganized Saiwo Pharmaceutical, and the angel round invested in the newly established Shenzhen Sciencare Medical Industries Co., Ltd.
- AprObtained the phase Ⅱ 、Ⅲ clinical trial approval documents of the National Center for Drug Evaluation.
2016
- AprComplete the phase I clinical trial, and submit the summary report to the National Center for Drug Evaluation.
2013
- MayThe Phase I clinical trial of naltrexone implant was launched.
2012
- NovNaltrexone implants were approved by the National Center for Drug Approval for Phase I clinical trials.
2011
- JulIn order to build a factory in Hunan, Siwo Co., Ltd. established Hunan Saiwo Pharmaceutical Co., Ltd.
2010
- AugSummarize the data of preclinical study and prepare to apply for clinical trial to National Center for Drug Examination.
2009
- DecThe animal experiment at the Beijing Zhaoyan New Drug Research Center was completed with good results.
2008
- DecShenzhen Siwo Co., Ltd. cooperated with Peking University to conduct research on the process and industrialization of naltrexone implants, and was approved as an industry-university-research project by the Ministry of Education of Guangdong Province in both years.
- MarThe research of the second-class new drug of naltrexone implants has entered the stage of animal testing (safety evaluation).
2007
- Jul
思沃公司将纳曲酮植入剂委托科研单位进行药学试验，该品种的新药研究工作正式启动。
2004
- Aug
思沃公司科研项目“抗复吸特效药纳曲酮长效缓释剂的研究和开发”在广东省科技厅立项为科技攻关项目。
2003
- May
Shenzhen Siwo Life Science Technology Co., Ltd. Has Published , Company’s bussiness aim is that researching effctive rehabilitation durgs.
Advisory
